Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 67.57% is 29% above its 5-year average of 52.53%, around the middle of its 5-year range (39.71%–90.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.23% above its 12-month average of 64.21%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 67.57%.
DEBT TO ASSETS RATIO
67.57%
DEBT TO ASSETS RATIO AVG TTM
64.21%
DEBT TO ASSETS RATIO AVG 3Y
55.46%
DEBT TO ASSETS RATIO AVG 5Y
52.53%
DEBT TO ASSETS RATIO AVG 10Y
40.53%
DEBT TO ASSETS RATIO AVG 15Y
31.54%
DEBT TO ASSETS RATIO AVG 20Y
23.39%
CURRENT VS TTM AVG
+5.23%
CURRENT VS 3Y AVG
+21.83%
CURRENT VS 5Y AVG
+28.64%
CURRENT VS 10Y AVG
+66.72%
CURRENT VS 15Y AVG
+114.20%
CURRENT VS 20Y AVG
+188.82%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+67467.76%
vs the sector median at left
Lifecore Biomedical, Inc.
Market Cap
$243.91M
Debt to Assets Ratio
67.57%
TTM Avg
64.21%
3Y Avg
55.46%
5Y Avg
52.53%
Market Cap
$244.47M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.25M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$250.09M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$237.08M
Debt to Assets Ratio
9.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.29M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | $243.91M | 67.57% | 64.21% | 55.46% | 52.53% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $244.47M | 0.00% | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.25M | 0.03% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $246.20M | 0.04% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $240.09M | 0.00% | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.09M | 0.03% | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | 0.33% | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $237.08M | 9.29% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.29M | 0.15% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $234.75M | 0.01% | N/A | N/A | N/A |
Debt/Assets
67.6%
Debt/Equity
9.64
Current Ratio
3.87
Interest Coverage
0.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 67.57% |
| 2026-03-31 | 66.58% |
| 2025-09-30 | 58.47% |
| 2025-05-25 | 54.66% |
| 2025-02-23 | 54.84% |
| 2024-11-24 | 51.43% |
| 2024-08-25 | 55.45% |
| 2024-05-26 | 52.60% |
| 2024-02-25 | 51.28% |
| 2023-11-26 | 48.92% |
| 2023-08-27 | 48.28% |
| 2023-05-28 | 44.42% |
| 2023-02-26 | 53.75% |
| 2022-11-27 | 57.68% |
| 2022-08-28 | 54.95% |
| 2022-05-29 | 90.20% |
| 2022-02-28 | 41.43% |
| 2021-11-30 | 43.44% |
| 2021-08-31 | 39.71% |
| 2021-05-31 | 42.92% |
| 2021-02-28 | 42.07% |
| 2020-11-30 | 39.30% |
| 2020-08-31 | 39.70% |
| 2020-05-31 | 40.85% |
| 2020-02-29 | 37.34% |
| 2019-11-30 | 38.48% |
| 2019-08-31 | 36.39% |
| 2019-05-31 | 29.38% |
| 2019-02-28 | 29.31% |
| 2018-11-30 | 20.75% |
| 2018-08-31 | 20.77% |
| 2018-05-31 | 18.02% |
| 2018-02-28 | 15.34% |
| 2017-11-30 | 15.41% |
| 2017-08-31 | 16.41% |
| 2017-05-31 | 15.08% |
| 2017-02-28 | 15.09% |
| 2016-11-30 | 16.11% |
| 2016-08-31 | 16.23% |
| 2016-05-31 | 18.04% |
| 2016-02-29 | 18.52% |
| 2015-11-30 | 13.35% |
| 2015-08-31 | 11.85% |
| 2015-05-31 | 12.27% |
| 2015-02-28 | 14.63% |
| 2014-11-30 | 13.84% |
| 2014-08-31 | 12.28% |
| 2014-05-31 | 10.96% |
| 2014-02-28 | 11.66% |
| 2013-11-30 | 12.63% |
| 2013-08-31 | 13.74% |
| 2013-05-31 | 15.23% |
| 2013-02-28 | 16.55% |
| 2012-11-30 | 18.60% |
| 2012-08-31 | 19.95% |
| 2012-05-31 | 21.24% |
| 2012-02-29 | 7.80% |
| 2011-11-30 | 8.36% |
| 2011-08-31 | 9.01% |
| 2011-05-31 | 9.61% |
| 2011-02-28 | 9.98% |
| 2010-11-30 | 10.54% |
| 2010-08-31 | 11.26% |
| 2010-05-31 | 11.87% |
| 2010-02-28 | 0.00% |
| 2009-11-30 | 0.00% |
| 2009-08-31 | 0.00% |
| 2009-05-31 | 0.00% |
| 2009-02-28 | 0.00% |
| 2008-11-30 | 0.00% |
| 2008-08-31 | 0.00% |
| 2008-05-31 | 0.00% |
| 2008-02-29 | 0.12% |
| 2007-11-30 | 0.12% |
| 2007-08-31 | 0.18% |
| 2007-05-31 | 0.02% |
| 2007-02-28 | 0.03% |
| 2006-11-30 | 0.03% |
| 2006-08-31 | 0.04% |
| 2006-05-31 | 1.70% |
| 2006-02-28 | 1.77% |
| 2005-11-30 | 8.56% |
| 2005-08-31 | 2.14% |
| 2005-05-31 | 3.09% |
| 2005-02-28 | 4.04% |
| 2004-11-30 | 8.83% |
| 2004-08-31 | 10.13% |
| 2004-05-31 | 9.67% |
| 2004-02-29 | 10.61% |
| 2003-11-30 | 18.90% |
| 2003-08-31 | 14.17% |
| 2003-04-30 | 14.53% |
| 2003-01-31 | 13.81% |
| 2002-10-31 | 16.27% |
| 2002-07-31 | 15.32% |
